European regulators approve J&J’s prostate cancer drug
Johnson & Johnson announced that the company’s investigational drug Zytiga (abiraterone acetate) has been approved by the European regulators. Zytiga
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine